Lethal effect of CD3-specific antibody in mice deficient in TGF-beta1 by uncontrolled flu-like syndrome

J Immunol. 2009 Jul 15;183(2):953-61. doi: 10.4049/jimmunol.0804076. Epub 2009 Jun 26.

Abstract

CD3-specific Ab therapy results in a transient, self-limiting, cytokine-associated, flu-like syndrome in experimental animals and in patients, but the underlying mechanism for this spontaneous resolution remains elusive. By using an in vivo model of CD3-specific Ab-induced flu-like syndrome, we show in this paper that a single injection of sublethal dose of the Ab killed all TGF-beta1(-/-) mice. The death of TGF-beta1(-/-) mice was associated with occurrence of this uncontrolled flu-like syndrome, as demonstrated by a sustained storm of systemic inflammatory TNF and IFN-gamma cytokines. We present evidence that deficiency of professional phagocytes to produce TGF-beta1 after apoptotic T cell clearance may be responsible, together with hypersensitivity of T cells to both activation and apoptosis, for the uncontrolled inflammation. These findings indicate a key role for TGF-beta1 and phagocytes in protecting the recipients from lethal inflammation and resolving the flu-like syndrome after CD3-specific Ab treatment. The study may also provide a novel molecular mechanism explaining the early death in TGF-beta1(-/-) mice.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / therapeutic use
  • Antibodies / toxicity*
  • Apoptosis
  • CD3 Complex / immunology*
  • Cause of Death
  • Cytokines / metabolism
  • Inflammation / chemically induced
  • Inflammation / etiology*
  • Inflammation / immunology
  • Mice
  • Mice, Knockout
  • Phagocytes / pathology
  • Syndrome
  • T-Lymphocytes / pathology
  • Time Factors
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / immunology*

Substances

  • Antibodies
  • CD3 Complex
  • Cytokines
  • Transforming Growth Factor beta1